Two-thirds of lost weight returns within a year of stopping a GLP-1. A physician explains five evidence-based strategies for keeping it off, and what the trials show.
Rep. Rosa DeLauro (D-Connecticut) is now calling out an interagency agreement that could allow potentially billions of NIH funds to be moved to the Department of Defense.
There is more needed to keeping kids safe online than the Meta settlement. The Retreat, a NY shelter and nonprofit, shared important advice and resources here.
A doctor breaks down what Americans need to know about flu, RSV, and COVID vaccines given different recommendations from the federal government and medical societies.
Two major cardiovascular trials, ZEUS and Lp(a)HORIZON, demonstrated that successfully altering a biological marker doesn’t guarantee improved patient outcomes.
America’s back-to-school season faces a critical challenge as crowded classrooms, waning immunity, & rising vaccine exemptions increase the risk of preventable diseases.
New trial results indicate that the targeted cancer drug Daraxonrasib might also be beneficial for some patients with lung cancer.
New trial results indicate that the targeted cancer drug Daraxonrasib might also be beneficial for some patients with lung cancer.
On Tuesday, the House, like the Senate had done a month ago, voted for a continuing resolution that would delay the new White House OMB rule until at least December 11.
More success for genetically engineered pig kidney transplants. Scientists might have found dark matter. Why space technologies and AI are converging. All that and more in this week’s Prototype.